Drugs Made In America Acquisition Corp. Units (DMAAU)
- Previous Close
10.16 - Open
10.00 - Bid 10.01 x 3000
- Ask 10.13 x 16700
- Day's Range
10.00 - 10.18 - 52 Week Range
10.00 - 10.82 - Volume
47,853 - Avg. Volume
71,826 - Market Cap (intraday)
296.676M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Drugs Made In America Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the pharmaceutical industry. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
dmaacorp.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: DMAAU
View MorePerformance Overview: DMAAU
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DMAAU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DMAAU
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-479.73k
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
1.35k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--